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Microenvironment interactions1. Introduction
While the biologic responses elicited by environmental stimuli vary
according to the target cells and the underlying biologic processes,
many researchers in the ﬁeld of cell biology have been focusing on the
innate potential of various cell types (Park et al., 2011; Seo et al.,
2004; Takahashi and Yamanaka, 2006). There has been particular inter-
est in development and regeneration at the stem-cell level, stem cells of
speciﬁc tissues, and reprogrammedpluripotent stem cells. Cells are con-
trolled by their microenvironment, which includes the external stimuli,
extracellular matrix, and signals from biologic processes. The environ-
mental condition around cells can regulate and control their character-
istics and behaviors (J. S. Lee et al., 2015; Rezza et al., 2014; Simon and
Keith, 2008). The hypoxic condition is one of the important factors
inﬂuencing the physiologic biology of stem cells and the pathologic bi-
ology of cancer cells. The environmental condition can affect cell growth
depending on the cell type:while a lack of oxygen availability due to the
enormously rapid proliferation of cancer cells would increase the risk ofK21 PLUS Project,
n-gu, Seoul 03722,
pen access article undermetastasis ormortality (Gilkes et al., 2014; Vaupel et al., 2004), this con-
dition would maintain the potentiality of multidirectional differentia-
tion and self-renewal of stem-cell niches (Maltepe and Simon, 1998;
Simon and Keith, 2008). The hypoxic condition is also known to be a fa-
vorable physiologicmicroenvironment for the development of embryos
and for the regulation of adult stromal cells. Since Morriss and New
(1979) ﬁrst reported the importance of the oxygen level in the ex
utero development of the mouse embryo, some researchers have inves-
tigated how the hypoxic condition maintains and regulates the
multipotency of cells during culturing (Fehrer et al., 2007; Fotia et al.,
2015).
Previous studies found that an oxygen level of 20% induced genetic
injury, cell senescence, and ﬁnally the loss of cell viability (Busuttil et
al., 2003; Chen et al., 1995; Parrinello et al., 2003), whereas reducing
the oxygen concentration to the physiologic level (2–9%) could improve
the genetic stability against cell aging and alter the direction of cell dif-
ferentiation in stem-cell biology (Fehrer et al., 2007; J. S. Lee et al.,
2015). Low oxygen availability can modify basic cell metabolism and
also enhance various pathways related to hypoxia-inducible factors
(HIFs), which can be removed via degradation in the presence of excess
oxygen. HIF-1 is especially well known to inﬂuence the transportation
of glucose by cells, angiogenesis, growth-factor signaling, cellular mi-
gration, and the growth and survival of cells (Giaccia et al., 2004;the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the importance of this protein and the oxygen level in stem-cell biology
for maintaining the self-renewal potential in stem-cell niches, the hom-
ing/migration of stem cells in wound-healing and inﬂammatory pro-
cesses, and the speciﬁc direction of cell differentiation (Simon and
Keith, 2008). Therefore, creating a hypoxic condition when culturing
bone marrow stromal cells has been a focus of research into possible
therapeutic interventions (J. S. Lee et al., 2015).
Clinical applications of stem cell grafts require tremendous numbers
of target cells to be produced in ex vivo expansion without losing their
regenerative potential. Achieving this requires an understanding of
the underlying mechanisms by mimicking the physiologic biology of
stem cells from quiescent stages in niches to proliferation/differentia-
tion in the wound-healing process. In the early phase wound healing,
HIFs enhance ﬁbroblast growth factor-2 (FGF-2) and ﬁnally increase
cellular proliferation. In an in vitro cell culture, the simultaneous use of
a hypoxic condition and FGF-2 treatment would be expected to exert
synergistic effects on the characteristics and behaviors of bone marrow
stromal cells, even though FGF-2 can also act as a morphogen on the
cells and hinder hypoxia-induced cellular responses. Therefore, the
present study aimed to determine the characteristics and behaviors of
cells expanded in media in a hypoxic or normoxic condition and with
or without FGF-2 treatment.2. Methods
2.1. Isolation and culture of human bonemarrow stromal cells from human
vertebral bodies
This study involved ﬁve volunteer patients (one male, four females;
age range 41–58 years, median age, 46 years) who provided informed
consent to participate based on guidelines approved by the Institutional
Review Board, College of Dentistry, Yonsei University, Seoul, Korea (ap-
proval no. 2-2012-0048). Mononuclear cells were obtained by centrifu-
gation with a density-gradient solution (Ficoll-Paque Plus, GE
Healthcare Bio-Sciences, Uppsala, Sweden) frombonemarrowaspirates
that had beenharvested directly from the vertebral bodyusing a speciﬁc
type of percutaneous puncture needle (VP Needle, OKMedinet Korea,
Seoul, Korea) during vertebral surgery (Naeun Hospital, Anyang,
Korea). The cells were seeded at a nonclonal density of 1000 cells/μl
with media containing alpha-minimum essential medium (α-MEM;
Gibco, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS; Gibco),
100 μM L-ascorbic acid 2-phosphate (Sigma-Aldrich, St. Louis, MO,
USA), 2 mM GlutaMAX-1 100× (Invitrogen, Carlsbad, CA, USA), and
20 μg/ml gentamicin (Gibco).2.2. Inducing a hypoxic condition and applying FGF-2 treatment
Isolated cells were cultured in the following four conditions accord-
ing to the oxygen level and FGF-2 treatment: normoxia/FGF-2(−),
normoxia/FGF-2(+), hypoxia/FGF-2(−), and hypoxia/FGF-2(+). Hyp-
oxia was induced by placing human bone marrow stromal cells
(hBMSCs) in a chamber containing 1% O2 at 37 °C (note that in
normoxia, the chamber contained 21% O2). The cells for the two exper-
imental groups with FGF-2 treatment were cultured in the presence of
5 ng/ml FGF-2 (Genoss, Seoul, Korea). The culture media was replaced
every 2 days, which included the addition of fresh FGF-2, and cells in
both hypoxia groupswere removed from the hypoxic chamber for feed-
ing but then immediately replaced in the chamber thereafter. All of the
cultureswere incubated at 37°C in 5% CO₂. Colony formation in each cul-
ture was observed with the aid of a light microscope (CKX41, Olympus
Optical, Tokyo, Japan). Adherent hBMSC-like cells were obtained after
2weeks of culture. Cells at passage 2 (P2) to P8were used in the further
analyses.2.3. Comparison of hBMSC characteristics between groups
2.3.1. Assay of colony-forming efﬁciency
The colony-forming efﬁciencywas evaluated based on the formation
of secondary colonies in which cells at P6 were plated at 1 × 102 cells/
dish onto 60-mm culture dishes (Nunc, Roskilde, Denmark) with cul-
ture media. They were ﬁxed 10–14 days later with 10% neutral buffered
formalin and then stainedwith crystal violet (Sigma-Aldrich). The num-
ber and size of colonies were calculated with the aid of a light micro-
scope in order to compare the colony-forming efﬁciencies.
2.3.2. Surface marker expression using ﬂuorescence-activated cell sorting
Cell-surface-marker characterization was applied to cells at P4 to
further characterize the isolated hBMSCs using ﬂow cytometry analysis
[ﬂuorescence-activated cell sorting (FACS)], the procedure for which is
described in detail elsewhere (Shim et al., 2016). Harvested cells were
transferred to a 15-ml tube (50015, SPL, Pocheon, Gyeonggido, Korea)
and washed with phosphate-buffered saline (PBS; 10010-023, Gibco).
Primary antibodies were conjugated with ﬂuorescent protein raised
against CD105, CD29, CD45, CD34, and CD14 (A07414, IM0791U,
A07783, IM1870, and IM0645U, respectively; Beckman Coulter, Brea,
California, USA) and CD44, CD73, and HLA-DR (555479, 550257, and
555611, respectively; BD Biosciences, Franklin Lakes, NJ, USA) for 1 h
at room temperature. Two types of surface markers were selected for
distinguishing adherent progenitor cells from mature cells (CD29,
CD44, CD73, and CD105) and from hematopoietic/immunogenic cells
(CD14, CD34, CD45, and HLA-DR). The cells were then washed with
PBS three times and observed with a ﬂow cytometer (CYTOMICS FC
500, Beckman Coulter).
2.3.3. In vitro differentiation assay: osteogenic, adipogenic, and
chondrogenic induction
Cells at P5 were seeded onto six-well plates at 1 × 105 cells/well and
cultured until they reached subconﬂuence. The protocols for in vitro dif-
ferentiation were used based on a previous study (J. S. Lee et al., 2015).
Brieﬂy, the culture medium for osteogenic differentiation comprised α-
MEM (Gibco) containing 10% FBS (Gibco), 20 μg/ml gentamicin (Gibco),
2 mM GlutaMAX-1 100× (Invitrogen), 100 μM L-ascorbic acid 2-phos-
phate (Sigma-Aldrich), 0.01 μM dexamethasone (Sigma-Aldrich), and
1.8 mM potassium phosphate monobasic (Sigma-Aldrich), and was
refreshed every 3–4 days. After 2–3 weeks of induction, mineralized
nodule formation was conﬁrmed as a marker of osteogenic differentia-
tion by staining with alizarin red. The culture medium for adipogenic
differentiation comprised α-MEM containing 10% FBS, 20 μg/ml genta-
micin, 2 mM GlutaMAX-1 100×, 100 μM L-ascorbic acid 2-phosphate,
500 μM isobutyl methyl xanthine (Sigma-Aldrich), 60 μM indomethacin
(Sigma-Aldrich), 0.5 μM hydrocortisone (Sigma-Aldrich), and 10 μg/ml
insulin (Sigma-Aldrich), and was refreshed every 3–4 days. After
3 weeks of induction, the cells were stained with Oil Red O stain in
order to visualize lipid droplets. Chondrogenic differentiation was in-
duced by seeding cells at P5 into 15-ml polypropylene tubes at 4 × 105
cells/tube to prevent cell adhesion, followed by centrifugation at 150g
for 5min to formapellet. The culturemedium for chondrogenic differen-
tiation comprised α-MEM (Gibco), 20 μg/ml gentamicin (Gibco), 1% in-
sulin-transferrin-selenium (BD Biosciences), 0.1 μM dexamethasone
(Sigma-Aldrich), 172 μM L-ascorbic acid 2-phosphate (Sigma-Aldrich),
40 μg/ml proline (Sigma-Aldrich), and 10 ng/ml transforming growth
factor-β3 (R&D Systems, Minneapolis, MN, USA), and was refreshed
every 3–4 days. After 3 weeks of inductionwith the chondrogenic differ-
entiation media, the pellets were ﬁxed using 4% neutral buffered forma-
lin, embedded in parafﬁn, and sectioned at a thickness of 5 μm. The
sections were stained with toluidine blue to assess chondrogenic
differentiation.
The formation of mineralized tissue was quantitatively evaluated by
analyzing hydroxyapatite deposition using the OsteoimageMineralized
Assay kit (Lonza, Walkersville, MD, USA), a ﬂuorescence plate reader
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software (version 2.4.3). In addition, a colorimetric assay for quantifying
alizarin red staining was performed, wherein stained cells were incu-
bated with a solution of 20% methanol and 10% acetic acid under
shaking conditions for 30 min. Supernatants containing dissolved
calcium from the cultured cells were then quantiﬁed by measuring the
absorbance at 450 nm using an ELISA microplate spectrophotometer
(K-BTK-EpochTak, BioTek,Winooski, VM,USA). The histomorphometric
analysis involved measuring the total areas of lipid vacuole formation
and chondrogenesis using an automated image-analysis system
(Image-Pro Plus, Media Cybernetics, Silver Spring, MD, USA).
2.3.4. In vivo regenerative potential of hBMSCs using an ectopic transplan-
tation model
In vivo transplantation was performed to evaluate the regenerative
capacity of hBMSCs. Hydroxyapatite/tricalcium phosphate (HA/TCP)-
based scaffolds were used as the cell carrier. For single transplantations,
6 × 106 cells at P6 were loaded with 80 mg of HA/TCP ceramic powder
(MBCP, Biomatlante, Vigneux, France) and then transplanted into sub-
cutaneous pockets formed on the dorsal surface of immunocompro-
mised mice (BALB/cSlc-nu, Japan SLC, Hamamatsu, Japan; 8 samples in
4 mice for each group). All animal experiments were carried out in ac-
cordancewith the guidelines and regulations for the use and care of an-
imals of the Animal Care Committee of the Medical College, Yonsei
University.
The mice were euthanized after 8 weeks of recovery, and the im-
plants were harvested and ﬁxed in 10% neutral buffered formalin for
3 days. The specimens were decalciﬁed using 5% EDTA (pH 7.2) and
then embedded in parafﬁn. The tissue was dissected to obtain the two
most-central 6-μm-thick sections, which were stained with Masson's
trichrome. In ten randomly selected high-magniﬁcation (×100) images
(two from the central region and two from each of the four corners on
the cross-sectional image of the grafted area), three types of tissue
could be found along with the residual biomaterial within the trans-
plants: mineralized tissue, ﬁbrous connective tissue, and bone mar-
row-like tissue (cell-rich zone). Two speciﬁc areas of bone formation
(mineralized tissue area) and bone marrow-like tissue (cell-rich zone
around or between mineralized tissues) were measured (Fang et al.,
2007; Miura et al., 2006) using image-processing computer software
(Photoshop CS5, Adobe, San Jose, CA, USA).
2.4. Cell proliferation assay
The proliferation rate of hBMSCs was assessed using the MTT assay
and calculating the doubling time (DT). In each passage, cell growth
wasmonitored by counting the number of cells using a hemocytometer
and trypan blue (for excluding necrotic cells), and DT was calculated as
(t2–t1)× log(2)/log(q2/q1),where q1 and q2 are the quantities that had
grown at times t1 and t2, respectively. For performing the MTT assay at
a speciﬁc time point, 4 × 104 cells at P5 were plated onto 6-well plates
and cultured with the medium for each of the 4 groups for 5 days.
After incubation with 10% MTT solution (5 mg/ml; Amresco, Solon,
OH, USA) and each culture medium for 4 h, the supernatant was
discarded, and the absorbance was measured at 570 nm using a micro-
plate spectrophotometer (EPOCH, BIOTEK, Winooski, VT, USA).
2.5. Cell migration assay
hBMSCs (1.5 × 106) were seeded onto 60-mm-diameter culture
dishes (BD Falcon, BD Sciences) and cultured to conﬂuence. The cells
were incubated with 5 μg/ml mitomycin C (Acros Organics, Waltham,
MA, USA) to limit the effects of cellular proliferation. The monolayer
cells on the dishes were scratched tomake a cell-free zone, and ﬂoating
cells were removed by rinsing with PBS. The distance reached by cells
that migrated over the following 72 h was measured with the aid of a
light microscope.2.6. Collagen-related gene expression
Gene expression related to the formation or maturation of collagen
was quantiﬁed using COL I–III for the formation of collagen and the
LOX family for the cross-linking of collagen ﬁbrils.
2.7. Quantitative real-time polymerase chain reaction
The quantitative real-time polymerase chain reaction (PCR) was
performed to further conﬁrm the other in vitro and in vivo results.
Cells were harvested using Trizol (GeneAll, Seoul, Korea), and total
cell RNA was prepared. Isolated total RNA was used as a template for
the synthesis of cDNA with oligo dT primer (High-Capacity RNA-to-
cDNA Kit, Applied Biosystems, Foster City, CA, USA). The subsequent
PCR ampliﬁcation was performed using a standard protocol with an
SYBR real-time PCR kit (Power SYBR Green PCR Master Mix, Life Tech-
nologies, Warrington, UK), the Step One Real-Time PCR system and as-
sociated software (Applied Biosystems), and speciﬁc primers of Apo1
(NM_000043.4), p21 (NM_000389.4), BMP-2 (NM_001200.2), LPL
(NM_000237.2), SOX9 (NM_000346.3), Aggrecan (NM_001135.3),
VCAN (NM_004385.4), COL I–III (NM_000088, NM_033150.2, and
NM_000090), LOX (NM_002317), and LOX 1–3 (NM_005576,
NM_002318, and NM_032603.2). After an initial polymerase activation
step at 95°C for 10min, the samples underwent 40 ampliﬁcation cycles,
each comprising denaturation at 95°C for 15 s, and annealing and exten-
sion at 60°C for 60 s. The real-time PCR data were analyzed using the
comparative CT method. The relative expression levels of mRNA were
quantiﬁed by comparison with an internal standard (B2M;
NM_004048.2) that is known to be a stable housekeeping gene regard-
less of the oxygen level. Each PCR was performed in triplicate with the
same total RNA.
2.8. Statistical analysis
Two-way analysis of variance was used to evaluate the effects of the
two factors (two oxygen levels and two conditions related to the use of
FGF-2) in all analyses except for microarray gene expression proﬁling.
Differences were considered statistically signiﬁcant when p b 0.05.
2.9. Microarray gene expression proﬁling
To evaluate cellular activity in each group based on gene-expression
proﬁling from eight types of cells in four groups of two individual sam-
ples, a bead-based microarray analysis (Human HT12 v4, Illumina, San
Diego, CA, USA) was performed in accordance with a previously de-
scribed protocol (J. S. Lee et al., 2015). Brieﬂy, total RNA extraction and
puriﬁcation were achieved using Trizol (Invitrogen) and the RNeasy
Mini kit (Qiagen, Hilden, Germany), and DNase digestion was per-
formed to eliminate DNA contamination. RNAs were ampliﬁed using
an ampliﬁcation kit (Ambion, Waltham, MA, USA) in accordance to
the manufacturer's instructions to yield biotinylated cRNA. After puriﬁ-
cation, the cRNA was quantiﬁed using a spectrophotometer (ND-1000,
NanoDrop, Wilmington, DE, USA). Labeled cRNA samples were hybrid-
ized onto a bead-array chip according to the manufacturer's instruc-
tions, and the signals were detected/scanned by Amersham FluoroLink
streptavidin-Cy3 (GE Healthcare, Buckinghamshire, UK) and an
Illumina Bead Array Reader confocal scanner.
Data from the bead-based microarrays were processed using the
Lumi package with background correction, normalization (quantile
method), and gene annotation. Analyses were performed using the
BRB-Array Tools software developed by Dr. Richard Simon and the
BRB-Array Tools Development Team, and SAM (signiﬁcance analysis of
microarrays) was applied. A previously reported direct transcriptional
target gene set of HIFs (Schoﬁeld and Ratcliffe, 2004) and the gene-
set-related glycolysis/gluconeogenesis from the KEGG (Kyoto Encyclo-
pedia of Genes and Genomes) database were used in these analyses.
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3.1. Assay of colony-forming efﬁciency
Various numbers of plastic adherent colonies of various sizes were
formed from the suspended single cells depending on the oxygen con-
centration and FGF-2 treatment in the culture environment (Fig. 1A
and B). The number of colonies was lower for cells cultured without
FGF-2 treatment in the hypoxia group than in the normoxia group
(17.00± 8.28% and 20.89± 8.88%, respectively;mean± SD); however,
the sizes of the colonies did not differ signiﬁcantly with the oxygen con-
centration (3.15 ± 0.34 and 3.21 ± 0.30 mm). FGF-2 treatment signiﬁ-
cantly increased the number of colonies [25.67 ± 11.95% and 23.78 ±
7.66% for the normoxia/FGF-2(+) and hypoxia/FGF-2(+) groups, re-
spectively] and their size (5.22±0.48 and 5.07±0.64mm, correspond-
ingly) and the density of cells within a colony, compared to both the
normoxia and hypoxia groups without FGF-2 treatment. All of the spec-
imens exhibited spindle-shaped cells in highly magniﬁed views, and a
particularly interesting ﬁndingwas that cells cultured with FGF-2 treat-
ment showed clearly distinguishable cellularmarginswith a pericellular
halo.
3.2. Surface marker expression (FACS)
All cells cultured in the four types of environment showed positivity
for CD29, CD44, CD73, and CD105 and negativity for hematopoietic/im-
mune cell markers (CD14, CD34, CD45, and HLA-DR). FGF-2 treatment
enhanced the expression levels of CD29 and HLA-DR in both oxygen
levels: CD29 expression was increased from 63.85 ± 14.35% to 92.60
± 1.27% in normoxia and from 50.95± 11.95% to 90.00± 2.69% in hyp-
oxia; the corresponding changes for HLA-DRwere from 1.30± 1.13% toFig. 1.Results from the colony-forming assay andﬂuorescence-activated cell sorting. (A andB)C
a slightly reduced number of colony-forming units compared to the normoxia/FGF(+) group. F
the normoxia and hypoxia conditions (p b 0.001). Smaller cells were observed with reduced c
normoxia, regardless of whether or not FGF-2 was applied. (C and D) All cells under the four c
and negativity for hematopoietic/immune cell markers (CD14, CD34, CD45, and HLA-DR). A r
enhancement by FGF-2 treatment. ⁎Statistically different from the hypoxic condition. #Statistic11.40± 5.52% and from 0.20± 0.14% to 4.35± 2.05%. However, the in-
creased amount of HLA-DR was reduced under hypoxia. Except for
CD29 and HLA-DR, the use of FGF-2 did not modify the cell-surface
markers. These patterns were also observed for cells from another pas-
sage (Fig. 1C and D).3.3. In vitro differentiation
The multidirectional differentiation capacity was evaluated by in-
ducing three types of cells from hBMSCs in each condition. Alizarin-
red-positive mineral depositions were signiﬁcantly enhanced in cells
cultured at the low oxygen level, but this was decreased by FGF-2 treat-
ment, whereas Oil-Red-O-positive vacuoles were signiﬁcantly reduced
and could be minimally observed in the cells at the low oxygen level.
These results were in accordance with BMP-2 gene expression increas-
ing in the hypoxic condition,while the ALPL and Runx2 gene expression
levels were signiﬁcantly reduced, regardless of the presence or absence
of FGF-2 treatment (Fig. 2A). However, the expression levels of all of the
adipogenic genes (LPL and AP2) were in agreement with the results
from the in vitro induction assay, and were signiﬁcantly decreased in
samples cultured in the hypoxic condition (Fig. 2B). Exceptionally,
PPAR-γ was signiﬁcantly enhanced in cells cultured in hypoxia and
with FGF-2. There was signiﬁcantly more glycosaminoglycan formation
within the pellet in the low-oxygen condition or with FGF-2 treatment,
with increased pellet size and a hyperchromic shift. Although no carti-
lage formationwas observedwhen using the late passage of hBMSCs re-
gardless of the environmental conditions, hypoxia and FGF-2 treatment
enhanced the formation of chondrogenesis-related products. The ex-
pression levels of related genes (SOX9, Col2A1, and Aggrecan) were in-
creased in cells cultured in the hypoxic condition,with the expression ofells culturedunder a lowoxygen levelwithout FGF-2 treatment [hypoxia/FGF(−)] showed
GF-2 treatment signiﬁcantly enhanced the proportion and size of colonies formed in both
ellular processes in highly-magniﬁed views of cultured cells under hypoxia compared to
onditions showed positivity for hBMSC-related markers (CD29, CD44, CD73, and CD105)
estricted supply of oxygen reduced the proportion of HLA-DR-positive cells, despite the
ally different from culturing without FGF-2.
Fig. 2.Results from the differentiation and ectopic transplantation assays. (A to C)Adipogenesiswas signiﬁcantly reduced in cells cultured under hypoxia compared to normoxia (p=0.01
for LPL and p=0.05 for AP2), while osteogenesis and chondrogenesis were enhanced. Although twomarkers (ALPL and Runx2) for osteogenesis were slightly but not signiﬁcant reduced
in hypoxia groups, BMP-2 signiﬁcantly increased in cells fromhypoxia groups (p=0.01), whichmight be related to the enhanced osteogenesis. The expression level of SOX9was higher in
hypoxia groups than in normoxia groups, and in FGF-2-treated groups than in untreated groups (p=0.01). (D and E) In the ectopic transplantation model, the formation of mineralized
tissue (bone; p= 0.001) and bone marrow-like zone (p= 0.03) around the grafted particles was increased in the hypoxic condition and with FGF-2 treatment, and also synergistically
when combined. ⁎Statistically different from the hypoxic condition. #Statistically different from culturing without FGF-2.
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neous-treatment condition (Fig. 2C).
3.4. In vivo transplantation
In an ectopic transplantation model, cells cultured in the four differ-
ent conditionswere evaluated for their in vivo differentiation capacities.
All of the samples exhibited mineralized tissue and bone marrow for-
mation;mineralized tissues could be observed on the surfaces of grafted
carrying biomaterials, and ﬁbrovascularmarrow tissueswere present in
the spaces between the grafted particles (Fig. 2D). The amount of bone
formation was signiﬁcantly increased in two conditions (hypoxia and
FGF-2 treatment), and this increased synergistically in samples from
the hypoxia/FGF-2(+) group: 0.28 ± 0.08, 0.94 ± 0.09, 0.62 ± 0.03,
and 1.83 ± 0 (mm2) in the normoxia/FGF-2(−), normoxia/FGF-2(+),
hypoxia/FGF-2(−), and hypoxia/FGF-2(+) groups, respectively. A par-
ticularly interesting observation was that (bone marrow-like) cell-richzones in ﬁbrovascular spaces appeared more frequently at sites that re-
ceived cells from both hypoxia groups, in which zonal clusters of mono-
nuclear cells were found: 0.010 ± 0.002, 0.10 ± 0.01, 0.05 ± 0.02, and
0.24 ± 0.05 (mm2), respectively (Fig. 2E).
3.5. Cell proliferation
Cellular proliferation assays were performed by calculating DT dur-
ing cell expansion and applying the MTT assay. Both assays revealed
similar patterns of proliferation: FGF-2 treatment reduced DT and in-
creased the formazan color intensity, and the low-oxygen condition af-
fected cell proliferation in an oppositeway to FGF-2 treatment (Fig. 3A).
However, the gene expression levels of two types of representative se-
nescencemarkers demonstrated that cell aging could be delayed in tan-
dem with the reduction of proliferation in the low-oxygen condition,
with this not being enhanced by FGF-2 treatment despite the enhance-
ment of cell proliferation—the normalized values of Apo1 and p21were
Fig. 3. Results from assays for proliferation, senescence, cell migration, and collagen formation. (A) The cellular proliferation rate was decreased in the hypoxia groups [extended DT (p b
0.001 for all passages) and reduced value in the MTT assay (p= 0.001 for 5-day samples)], while FGF-2 treatment had the opposite effect on cell proliferation. The expression levels of
representative markers for senescence (Apo1 and p21; p b 0.001 for both genes) were decreased in cells under the hypoxic condition and with FGF-2 treatment. (B) Cellular migratory
activity was also enhanced in the hypoxic condition and with FGF-2 treatment (p= 0.001). VCAN gene expression was increased in the hypoxic condition (p b 0.001), which is related
to the reduced adhesion and migration of cells, and this was not affected by FGF-2 treatment. (C) The expression levels of all genes associated with collagen formation (COL I–III) and
maturation (LOX family) were signiﬁcantly enhanced in a hypoxic condition, and this pattern was synergistically strengthened in a hypoxic condition accompanied with FGF-2
treatment. ⁎Statistically different from the hypoxic condition. #Statistically different from culturing without FGF-2.
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and 0.56± 0.03, and 0.27± 0.02 and 0.29± 0.04 in the normoxia/FGF-
2(−), normoxia/FGF-2(+), hypoxia/FGF-2(−), and hypoxia/FGF-2(+)
groups, respectively (Fig. 3A).3.6. Cell migration
Cells migrated at various speeds depending on their culture condi-
tions. Both experimental conditions (FGF-2 treatment and a low oxygen
level) signiﬁcantly enhanced the migration distance from the
preexisting cell culture margin, especially for FGF-2 treatment:
1425.21 ± 58.26, 1969.12 ± 146.94, 1578.95 ± 126.06, and 2124.23
± 90.36 μm in the normoxia/FGF-2(−), normoxia/FGF-2(+), hypoxia/
FGF-2(−), and hypoxia/FGF-2(+) groups, respectively. The expression
of the VCAN gene, which is related to the anti-adhesion and migrationof cells, was increased in the hypoxic condition, and this was not af-
fected by FGF-2 treatment (Fig. 3B).
3.7. Collagen-related gene expression
The expression levels of all genes associatedwith collagen formation
(COL I–III) andmaturation (LOX family) were signiﬁcantly enhanced by
a low oxygen level, and this pattern was synergistically strengthened in
a hypoxic condition accompanied with FGF-2 treatment. However, COL
II and LOX 1 were exceptionally decreased in samples cultured in a
normoxic condition with FGF-2 treatment (Fig. 3C).
3.8. Microarray gene expression proﬁling
For evaluating the effects of FGF-2 treatment on the hypoxia-in-
duced cellular responses at the gene expression level, microarray
Fig. 4. Analytic results frommicroarray gene expression proﬁling. (A) Scatter plots of the expression levels of HIF-related genes between different groups showed ﬂuctuations in the gene
expression patterns between the hypoxic and normoxic conditions, but onlyminor effects of FGF-2 treatment. (B) In clustering analyses based on gene sets related to theHIF pathway and
glycolysis (Supplementary Table 1), all samples clustered according to the two oxygen levels, independently of FGF-2 treatment. (C) The quantitative PCR revealed the same pattern of
expression levels of representative HIF-related genes (PGK1, BNIP3, CA9, HK2, ALDOC, TPI, and HIF-1a) as in the microarray data. ⁎Statistically different from the hypoxic condition.
#Statistically different from culturing without FGF-2.
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colysis, which are known to be representative genes related to hypoxia-
induced cellular responses. Scatter plots of the expression levels of HIF-
related genes between different groups revealed ﬂuctuations in the
gene expression patterns between the hypoxic and normoxic condi-
tions, regardless of the FGF-2 treatment. In both normoxic and hypoxic
conditions, the data points in scatter plots were concentrated around
the line indicating a directly proportional relationship between groups
with and without FGF-2 treatment (Fig. 4A). In clustering analyses
based on these two gene sets, all samples were clustered according to
the two oxygen levels, regardless of FGF-2 treatment (Fig. 4B and Sup-
plementary Table 1). The quantitative PCR revealed the same patternof expression levels of representative HIF-related genes (PGK1, BNIP3,
CA9, HK2, ALDOC, TPI, and HIF-1a) as in the microarray data (Fig. 4C).
4. Discussion
A low oxygen level reduces the proliferation rate of cells (Itahana et
al., 2003; Kondoh et al., 2005; Parrinello et al., 2003) despite it also sup-
pressing cell senescence (Chen et al., 1995; A. C. Lee et al., 1999). The
present study focused on two issues related to ex vivo hBMSC cultures:
(1) maintaining cellular characteristics in a hypoxic condition and (2)
enhancing cellular proliferation using FGF-2. In senescence characteris-
tics of laboratory cell cultures changedwith the culture passage, and our
94 J.-S. Lee et al. / Stem Cell Research 28 (2018) 87–95preliminary experimental data also showed that the number of colonies
decreased signiﬁcantly for cells after P5 on average (Supplementary Fig.
1). The expression of a speciﬁc progenitor cell marker (CD29) was sig-
niﬁcantly reduced in late-passage cells in the present study, and so all
of the experiments used stromal cells at P6 when evaluating the effects
of hypoxia and FGF-2 on the late passage of cells.
A restricted supply of oxygen alters cellular metabolism to the oxy-
gen-independent pathway, glycolysis, and this could modulate the cel-
lular life span (Kondoh et al., 2005) and stabilize the multipotency of
human bone marrow stromal cells (Estrada et al., 2012). These mecha-
nisms are consistent with the present study ﬁnding that eight samples
could be clustered into two other groups (hypoxia and normoxia) by
microarray analysis based on the glycolysis-related gene set. Along
with the changes in gene expression, the in vitro cellular responses dif-
fered in cells cultured in the hypoxic condition, with the reduction of
cellular proliferation and the expression of senescence markers in hyp-
oxia. These ﬁndings are in agreement with previous studies showing
continuous increases in population doubling via activation of the glyco-
lytic enzyme (Kondoh et al., 2005) and the reduction of telomere short-
ening in bonemarrow stromal cells (Estrada et al., 2012). In the present
study, the hypoxic condition also modiﬁed the differentiation patterns
of hBMSCs. A low oxygen level limits the utilization of fatty acid,
whosemetabolism includes the use of oxygen inmitochondrial respira-
tion (Simon and Keith, 2008; Yun et al., 2002).
For results for osteogenic differentiation indicated that the patterns
of gene expression were inconsistent with the mineral deposition (in-
creased BMP-2 but reduced ALP and Runx2), which was consistent
with the results from our previous study (J. S. Lee et al., 2015). The lim-
itations of the in vitro cell culture system mean that these observations
should be interpreted in combination with previous results (including
from in vivo transplantation) that showed similar patterns of enhanced
new bone formation under a hypoxic condition. Although a lower oxy-
gen level may enhance osteogenic differentiation, the present results
suggest that FGF-2 has only minor effects during this process. Consider-
ing these cellular responses, the additional application of FGF-2 might
not interrupt the shifted cellular conditions when culturing in hypoxia
(J. S. Lee et al., 2015; Rajpurohit et al., 1996; Schipani et al., 2001). The
present microarray data showed that samples clustered according to
the oxygen level only (i.e., independent of FGF-2 treatment), which
might indicate that FGF-2 treatment does not signiﬁcantly affect the
two critical pathways for hypoxia-induced cellular responses. Scatter
plots for an HIF-1-related gene set also showed signiﬁcant alterations
of expression in the hypoxic condition, while HIF-1-related genes
were expressed similarly in groups with and without FGF-2 treatment
in both the normoxic and hypoxic conditions.
The homing of mesenchymal stromal cell is the critical ﬁrst step in
the process of regeneration. Progenitor cells would be detached andmi-
grate to the wound or remodeling site in the response to a chemotactic
stimulus, and greatermigratory activity ofmarrow stromal cells can en-
hance the process of tissue regeneration. In the present study, hBMSCs
cultured in the environment of hypoxia with or without FGF-2 showed
signiﬁcant increases in cellularmigration, even though the hypoxic con-
dition reduced cellular proliferation. This is in accordance with the en-
hanced regenerative potential of differentiation and colony-forming
efﬁciency in late-passage cells. Functions from HIF-related pathways
were controlled by degradation of HIF-1 in the presence of sufﬁcient ox-
ygen, rather than by controlling its production. Previous studies found
that reducing HIF-1 degradation by restricting the supply of oxygen af-
fected various pathways related to the biologic characteristics of cancer
cells and stem cells (Gilkes et al., 2014; Simon and Keith, 2008), includ-
ing the HIF-1 pathway and glycolysis. The changes in the underlying
mechanisms will result in cellular phenotypes differing signiﬁcantly in
terms of their proliferation, migration, and differentiation.
One of the concerns when using FGF-2 in a culturing technique for
bonemarrow stromal cells is the possibility of limiting themultipotency
of cells, with increasing cellular proliferation. In the present result, thesurface markers for bone marrow stromal cells were not changed in
any of the experimental groups, whereas HLA-DR increased with FGF-
2 treatment. A previous study similarly showed increases in HLA-DR
of mesenchymal stromal cells by FGF-2 treatment, and suggested that
the numbers of human mesenchymal stromal cells could be controlled
by the engagement of immunologic processes from increased HLA-DR
expression (Bocelli-Tyndall et al., 2010). However, hypoxia can reduce
the expression of HLA-DR induced by FGF-2 and also recover the in-
crease in CD29 expression, and both environmental conditions may
synergistically and complementarily affect hBMSCs so as to enhance
the regenerative potential of hBMSC and increase their proliferation
rate while maintaining the cellular purity in populations of mesenchy-
mal stromal cells.
Culturing hBMSCs using a particular environmental condition (hyp-
oxia) with the addition of FGF-2 increased the cellular proliferation rate
while enhancing the regenerative potential for bone tissue engineering,
modulating multipotency-related processes (enhanced chondrogene-
sis-related processes, reduced adipogenesis, and with a compensatory
increase in the reduced osteogenesis induced by hypoxia only), and in-
creased cellular migratory/collagen formation activity. However, hyp-
oxia did not reverse the senescence of hBMSCs, such as a loss of
chondrogenesis. The gene expression levels in the experimental sam-
ples showed activation of the HIF-1 pathway and glycolysis in the hyp-
oxic condition, but the addition of FGF-2 did not affect the hypoxia-
induced biologic activity.
We propose the concurrent application of the hypoxic condition and
FGF-2 as a putative methodology for culturing hBMSCs for use in bone
tissue engineering. However, this conclusion is based on experiments
of pooled hBMSCs rather than each individual colony, and so future
studies need to investigate the clinical application of grafting colonies
of hBMSCs cultured in hypoxia and FGF-2.
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